Timothée Olivier
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Timothée Olivier
Jul 24, 2024, 01:01 |
Blog
Timothée Olivier: Interim data of early phase results from novel RAS inhibitor in pancreatic cancer
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared his previous post on X,…
Jul 5, 2024, 06:31 |
Blog
Timothée Olivier: CDK4/6 inhibitors as adjuvant therapy in ER+ /HER2- early breast cancer
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X: "Our…
Jul 3, 2024, 01:59 |
Blog
Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands
Schnog John-John, Medical Doctor at Curacao Medical Center, shared a post on X: “Cancer patient…
Jun 29, 2024, 04:26 |
Blog
The THEOREMM Project by Timothée Olivier and team
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared…
Jun 27, 2024, 12:11 |
Insight
Patrick Forde: What is an acceptable rate of crossover?
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at…
Jun 24, 2024, 01:26 |
Blog
Timothée Olivier: Postrecurrence Treatment in Neoadjuvant or Adjuvant FDA Registration Trials
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
Jun 23, 2024, 11:08 |
Drugs
Vinay Prasad: We look at all Adjuvant and Neoadjuvant drugs approved by FDA in last 5 years
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
Jun 22, 2024, 12:13 |
Blog
Ade Adamson: Nice write up by Timothée Olivier and Vinay Prasad on our melanoma overdiagnosis paper
Timothée Olivier shared a post by Ade Adamson, Assistant professor in the Department of Internal Medicine…
Jun 19, 2024, 08:32 |
Blog
Timothée Olivier: Vinay Prasad and I discussed top abstracts of ASCO24
Timothée Olivier recently shared a post on X: "Post ASCO! Vinay Prasad and I discussed…
May 28, 2024, 14:05 |
Blog
Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
May 27, 2024, 06:35 |
Blog
Timothée Olivier: An academic study addressing a practical clinical question!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:…
May 24, 2024, 14:53 |
Insight
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
May 22, 2024, 04:25 |
Blog
Timothée Olivier: One of the most important and practice-changing piece this year
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X…
May 5, 2024, 07:48 |
Blog
Timothée Olivier: The regulatory failure of sotorasib in lung!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals shared a thread on X:…
Apr 5, 2024, 18:16 |
Insight
Timothée Olivier: NATALEE trial, adjuvant ribociclib 21 days/28 for… 3 years! Cost alert!!
Timothée Olivier, Medical Oncologist at HUG - Geneva University Hospitals, shared a post by the…
Mar 26, 2024, 13:13 |
Blog
Timothée Olivier: Important findings for health policy
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, recently shared on X/Twitter: “Out…
Mar 5, 2024, 01:35 |
Insight
Timothée Olivier: Final results of ASCENT in patients with TNBC…
Timothée Olivier, Clinic Director at HUG – Geneva University Hospitals, shared the following post by Markus…
Feb 24, 2024, 11:26 |
Insight
Timothée Olivier: One of my favorite paper with Vinay
Timothée Olivier, Clinic Director at HUG – Geneva University Hospitals, shared the following post by…
Oct 10, 2023, 00:40 |
Blog
Timothée Olivier: Wow, a long awaited decision about the CodeBreaK 200 trial... with a PFS per BICR considered... unreliable!
Timothée Olivier, Clinic Director at HUG - Geneva University Hospitals, shared the following post by…
Jul 24, 2023, 18:23 |
Drugs
These drugs are $$$! i.e. avapritinib = $44,000/bottle - Michael Lam
Patients on oral chemo after dose reduction: "I still have these pills at home, but…
All:
20
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube